Bank of America
CAI

Bank of America’s Caris Life Sciences CAI Stock Holding History

Bank of America’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.36M Sell
523,268
-599,480
-53% -$13.1M ﹤0.01% 3016
2025
Q4 		$30.3M Buy
1,122,748
+693,270
+161% +$19.5M ﹤0.01% 1941
2025
Q3 		$13M Buy
429,478
+394,289
+1,120% +$12.6M ﹤0.01% 3037
2025
Q2 		$940K Buy
+35,189
New +$948K ﹤0.01% 5339

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America's CAI Position: Q1 2026 in Review

Bank of America reduced its Caris Life Sciences (CAI) stake by 53% in Q1 2026, selling an estimated $13.1M and leaving 523,268 shares worth $9.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

Bank of America first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $30.3M in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Bank of America held 523,268 shares of Caris Life Sciences worth $9.36M as of Q1 2026.
  • Bank of America sold 599,480 Caris Life Sciences shares in Q1 2026, an estimated $13.1M.
  • Caris Life Sciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3016 holding.
  • Bank of America first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Bank of America's Caris Life Sciences position peaked at $30.3M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.